Liver Fibrosis
📧 Sign up to get email alerts when something new happens for Liver Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis. [Phase 2]
Phase 2 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD2389 in participants with liver fibrosis and com…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Clinical trial results in Zambian HIV-HBV co-infected patients evaluated liver fibrosis outcomes; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
A National Institute of Allergy and Infectious Diseases-sponsored trial evaluating liver fibrosis and steatohepatitis in HIV-infected patien…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]
Phase 4 clinical trial comparing an early time-restricted eating Mediterranean diet to naltrexone/bupropion for liver fibrosis in adults wit…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
This clinical trial update reports on the mechanisms of microbial translocation across the spectrum of HCV-associated liver fibrosis, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis [Phase 3]
A Phase 3 clinical trial named LIVERAGE is evaluating Survodutide for metabolic dysfunction-associated steatohepatitis (MASH) with moderate …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated the combination of dasatinib and quercetin for fibrotic non-alcoholic fatty liver disease (NA…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
This clinical trial entry describes a study comparing S-Viscosity and Canon Dispersion Slope in metabolic dysfunction-associated steatotic l…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
A recruiting clinical study uses single-cell multiomics and spatiotemporal omics to investigate mechanisms of liver degeneration. Sponsored …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis
A clinical trial from Assiut University investigates the relationship between hs-CRP, triglycerides, and a glucose index with liver fibrosis…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes [NA]
This clinical trial update notes a NOT_YET_RECRUITING study evaluating screening for MASLD-related advanced liver fibrosis in people with ty…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Volatile Organic Compounds for the Assessment of Liver Disease
A completed clinical trial evaluating volatile organic compounds for the assessment of liver disease.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis [Phase 1, Phase 2]
A Phase 1/2 trial of oral idebenone for non-alcoholic steatohepatitis with fibrosis has completed and posted results.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes
This clinical trial update outlines a study to determine how common MASLD is and what risk factors are associated with metabolic-associated …
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation
This clinical trial update reports completion of a study on non-invasive MRI methods to evaluate liver fibrosis and inflammation.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver Fibrosis
A clinical trial update notes ongoing recruitment for a rapid breath-hold imaging method to quantify macromolecular proton fraction in liver…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Incidence of Liver Disease-Related Outcomes in People With HIV
This is an ongoing clinical trial evaluating liver disease–related outcomes in people living with HIV, focusing on metabolic liver condition…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Copper Supplementation in Cirrhosis [NA]
An ongoing University of Washington clinical trial is evaluating copper supplementation in patients with liver disease, including cirrhosis …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: [¹⁴C] Hydronidone Mass Balance Study [Phase 1]
Phase 1 mass balance pharmacokinetic study of [14C] Hydronidone in patients with chronic hepatitis B-related liver fibrosis; the trial is no…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Exercise for an Aging Liver (EXALIVER) [NA]
EXALIVER is a clinical trial evaluating exercise as an intervention for MASLD and MASH-related liver disease, with the study currently not y…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein [Phase 3]
Phase 3 study to assess the safety and potential efficacy of Fazirsiran for liver disease and fibrosis caused by an abnormal alpha-1 antitry…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: City-Hospital Collaboration for Early Detection of Liver Fibrosis in Primary Care: A Secondary Prevention Project in the Grenoble Health Area
A clinical trial update describing a city-hospital collaboration in Grenoble aimed at early detection of liver fibrosis in primary care as a…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
A clinical trial is recruiting to evaluate MR elastography as a noninvasive method to assess liver fibrosis in patients with chronic hepatit…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Liver Cancer Prevention Randomized Control Trial [NA]
This clinical trial update reports an active-not-recruiting randomized controlled trial aimed at preventing liver cancer. The study lists MD…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans [Phase 2]
A Phase 2 clinical trial is investigating thyroid hormone as a treatment for nonalcoholic steatohepatitis with liver fibrosis in veterans, a…